Evaluation of the Efficacy of a New Supplement for Hair and Nails - in Vitro, Clinical, Subjective and Instrumental Study

Hair Loss Clinical Trial

Official title: Avaliação da eficácia de um Novo Suplemento Alimentar Para Cabelos e Unhas- Estudo in Vitro, clínico, Subjetivo e Instrumental

Status Completed

Clinical Trial Summary

A unicentric, exploratory, prospective clinical an in vitro study to evaluate efficacy and safety of a Supplement in improving the quality and general aspects of hair and nails in female participants through clinical,in vitro, subjective and instrumental evaluations

Clinical Trial Description

A unicentric, exploratory, prospective clinical an in vitro study to evaluate efficacy and safety of a Supplement in improving the quality and general aspects of hair and nails in female participants through clinical, in vitro, subjective and instrumental evaluations.

It will be necessary 40 female participants aged between 25 and 55 years old with a clinical and in vitro diagnosis of telogen effluvium presenting at least one of the following characteristics: hair loss problems caused by stress, poor diet and excess of tinctures and chemicals procedures applied to hair, and menopausal women.

The participants will remain in the study for 93 days using the product. Visits will be scheduled in D-3, D0, D45, D48, D90, D93.

Instrumental evaluations: Evaluated on each visit:

• To analyze the biological cycle of hair growth using Trichogram test - D-3, D45, D90;

• Evaluation of hair growth kinetics using phototrichogram - D-3,D0, D45, D48, D90, D93;

• Evaluation of the mechanical strength of the hair structure using EMIC DL 500- D-3, D90

• Evaluation of the dermal density of the scalp using the high-frequency ultrasound- D-3, D45, D90

• Participants will respond to a subjective assessment using a questionnaire to capture a subjective efficacy- D45, D90 ;

Related Conditions & MeSH terms

• Alopecia
• Alopecia Areata
• Hair Loss
• Nails, Ingrown

• NCT number: NCT05945979
• Study type: Interventional
• Source: Farmoquimica S.A.
• Status: Completed
• Phase: N/A
• Start date: March 7, 2022
• Completion date: June 1, 2022